The following article was featured in:
Source:
stylemagazine.com stories: Health
04/04/2024.
Amylyx Pharmaceuticals announced Thursday that it has begun the process of voluntarily withdrawing its ALS drug, Relyvrio, from the market after it failed to prove efficacy in a large clinical trial.
Continue on to full article...